Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M, 2020, 'Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial', Annals of Oncology, vol. 31, pp. 1553 - 1560, http://dx.doi.org/10.1016/j.annonc.2020.07.020
Moth EB; Kiely BE; Martin A; Naganathan V; Della-Fiorentina S; Honeyball F; Zielinski R; Steer C; Mandaliya H; Ragunathan A; Blinman P, 2020, 'Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences', Journal of Geriatric Oncology, vol. 11, pp. 626 - 632, http://dx.doi.org/10.1016/j.jgo.2019.07.026
Tervonen HE; Chen TYT; Lin E; Boyle FM; Moylan EJ; Della-Fiorentina SA; Beith J; Johnston A; Currow DC, 2019, 'Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia', European Journal of Cancer Care, vol. 28, http://dx.doi.org/10.1111/ecc.13125
Chin-Lenn L; De Boer RH; Segelov E; Marx GM; Hughes TM; McCarthy NJ; White SC; Foo SS; Rutovitz JJ; Della-Fiorentina S; Jennens R; Antill YC; Tsoi D; Cronk MF; Lombard JM; Kiely BE; Chirgwin JH; Gorelik A; Mann GB, 2018, 'The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 410 - 416, http://dx.doi.org/10.1111/ajco.13075
Girgis A; Durcinoska I; Gerges M; Kaadan N; Arnold A; Descallar J; Delaney GP; Avery S; Carolan M; Della-Fiorentina S; Masters K; Miller A; Ng W; Sandell T; Tran TT; Levesque JV, 2018, 'Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4729-3
Colleoni M; Luo W; Karlsson P; Chirgwin J; Aebi S; Jerusalem G; Neven P; Hitre E; Graas MP; Simoncini E; Kamby C; Thompson A; Loibl S; Gavilá J; Kuroi K; Marth C; Müller B; O'Reilly S; Di Lauro V; Gombos A; Ruhstaller T; Burstein H; Ribi K; Bernhard J; Viale G; Maibach R; Rabaglio-Poretti M; Gelber RD; Coates AS; Di Leo A; Regan MM; Goldhirsch A; Vandebroek A; Berliere M; Mitine C; Vuylsteke P; Borms M; D'Hondt R; Glorieux P; Mebis J; Verhoeven D; Coibion M; Forget F; Duck L; Wyendaele W; Barbeaux A; Salmon JP; Berteloot P; Vermeij J; Richard V; Cinieri S; Gianni L; Clerico M; Pinotti G; Bernardo A; Biganzoli L; Gennari A; Graiff C; Amadori D; Passalacqua R; Forbes J; Francis P; Foo S; Boyle F; Redfern A; van der Westhuizen A; Lewis C; Sharma S; Beale P; Byard I; Begbie S; Sardelic F; Abdi E; Clark D; Chindewere A; Della-Fiorentina S; Asghari R; Islam M; Na Teo L; White S; Gilbert L; Gardner K; Uhlmann C; Rauch D; Mannhart M; Buser K; Dedes K; Mueller A; Rageth C; Von Orelli S; Senn HJ; Pagani O; Pedrazzini A; Rochlitz C; Bodmer A; Anchisi S; Zaman K; von Moos R; Betticher D, 2018, 'Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial', The Lancet Oncology, vol. 19, pp. 127 - 138, http://dx.doi.org/10.1016/S1470-2045(17)30715-5
Girgis A; Durcinoska I; Delaney GP; Koh ES; Ng W; Arnold A, 2018, 'Development of health pathways to standardize cancer care pathways informed by patient-reported outcomes and clinical practice guidelines', JCO Clinical Cancer Informatics, vol. 2018, pp. 1 - 13, http://dx.doi.org/10.1200/CCI.18.00024
Ip E; Pokorny AMJ; Della-Fiorentina S; Beale P; Bray V; Kiely BE; Blinman P, 2017, 'Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres', Internal Medicine Journal, vol. 47, pp. 75 - 81, http://dx.doi.org/10.1111/imj.13296
Girgis A; Delaney GP; Arnold A; Miller AA; Levesque JV; Kaadan N; Carolan MG; Cook N; Masters K; Tran TT; Sandell T; Durcinoska I; Gerges M; Avery S; Ng W; Della-Fiorentina S; Dhillon HM; Maher A, 2016, 'Development and Feasibility Testing of PROMPT-Care, an eHealth System for Collection and Use of Patient-Reported Outcome Measures for Personalized Treatment and Care: A Study Protocol', JMIR RESEARCH PROTOCOLS, vol. 5, http://dx.doi.org/10.2196/resprot.6459
Zdenkowski N; Forbes JF; Boyle FM; Kannourakis G; Gill PG; Bayliss E; Saunders C; Della-Fiorentina S; Kling N; Campbell I; Mann GB; Coates AS; Gebski V; Davies L; Thornton R; Reaby L; Cuzick J; Green M, 2016, 'Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial', Annals of Oncology, vol. 27, pp. 806 - 812, http://dx.doi.org/10.1093/annonc/mdw055
Moth EB; Parry J; Stockler MR; Beale P; Blinman P; Della-Fiorentina S; Kiely BE, 2015, 'Doctor-to-doctor communication of prognosis in metastatic cancer: A review of letters from medical oncologists to referring doctors', Internal Medicine Journal, vol. 45, pp. 909 - 915, http://dx.doi.org/10.1111/imj.12776
Lakhanpal R; Yoong J; Joshi S; Yip D; Mileshkin L; Marx GM; Dunlop T; Hovey EJ; Della Fiorentina SA; Venkateswaran L; Tattersall MHN; Liew S; Field K; Singhal N; Steer CB, 2015, 'Geriatric assessment of older patients with cancer in Australia-A multicentre audit', Journal of Geriatric Oncology, vol. 6, pp. 185 - 193, http://dx.doi.org/10.1016/j.jgo.2015.03.001
Sandy J; Della-Fiorentina S, 2013, 'Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic', Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 365 - 372, http://dx.doi.org/10.1111/ajco.12093
Ramalingam S; Crawford J; Chang A; Manegold C; Perez-Soler R; Douillard JY; Thatcher N; Barlési F; Owonikoko T; Wang Y; Pultar P; Zhu J; Malik R; Giaccone G; Della-Fiorentina S; Begbie S; Jennens R; Dass J; Pittman K; Ivanova N; Koynova T; Petrov P; Tomova A; Tzekova V; Couture F; Hirsh V; Burkes R; Sangha R; Ambrus M; Janaskova T; Musil J; Novotny J; Zatloukal P; Jakesova J; Klenha K; Roubec J; Vanasek J; Fayette J; Bennouna-Louridi J; Chouaid C; Mazières J; Vallerand H; Robinet G; Souquet PJ; Spaeth D; Schott R; Lena H; Martinet Y; El Kouri C; Baize N; Scherpereel A; Molinier O; Fuchs F; Josten KM; Marschner N; Schneller F; Overbeck T; Thomas M; von Pawel J; Reck M; Schuette W; Hagen V; Schneider CP; Georgoulias V; Varthalitis I; Zarogoulidis K; Syrigos K; Papandreou C; Bocskei C; Csanky E; Juhasz E; Losonczy G; Mark Z; Molnar I; Papai-Szekely Z; Tehenes S; Vinkler I; Almel S; Bakshi A; Bondarde S; Maru A; Pathak A; Pedapenki RM; Prasad K; V S S Prasad S; Kilara N; Gorijavolu D; Deshmukh CD; John S; Sharma LM; Amoroso D; Bajetta E; Bidoli P; Bonetti A; De Marinis F; Maio M; Passalacqua R; Cascinu S; Bearz A; Bitina M, 2013, 'Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)', Annals of Oncology, vol. 24, pp. 2875 - 2880, http://dx.doi.org/10.1093/annonc/mdt371
Fox PN; Chatfield MD; Beith JM; Allison S; Della-Fiorentina S; Fisher D; Turley K; Grimison PS, 2013, 'Factors delaying chemotherapy for breast cancer in four urban and rural oncology units', ANZ Journal of Surgery, vol. 83, pp. 533 - 538, http://dx.doi.org/10.1111/j.1445-2197.2012.06254.x
Ng WL; Della-Fiorentina SA, 2010, 'The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit', European Journal of Cancer Care, vol. 19, pp. 403 - 407, http://dx.doi.org/10.1111/j.1365-2354.2009.01068.x
Al Bahrani BJ; Moylan EJ; Forouzesh B; Della-Fiorentina SA; Goldrick AJ, 2009, 'A short outpatient hydration schedule for cisplatin administration.', The gulf journal of oncology, pp. 30 - 36
Ellis PM; Delaney GP; Della-Fiorentina SA; Moylan EJ, 2004, 'Assessing outcomes of cancer care: Lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996¿July 2000', Journal of Medical Imaging and Radiation Oncology, vol. 48, pp. 364 - 370, http://dx.doi.org/10.1111/j.0004-8461.2004.01320.x
Delaney G; Hui A; Berry M; Fowler A; Kneebone A; Barton M; Shakespeare T; Campbell G; Della-Fiorentina S; Brown K, 1999, 'Don't block the new kids', Australasian Radiology, vol. 43, pp. 562
Della-Fiorentina SA; Jaworski RC; Crandon AJ; Harnett PR, 1996, 'Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary.', The Australian and New Zealand journal of surgery, vol. 66, pp. 124 - 125, http://dx.doi.org/10.1111/j.1445-2197.1996.tb01133.x
Dai E; Della-Fiorentina S, 2018, 'The incidence and severity of breakthrough nausea and vomiting with palonosetron and dexamethasone requiring addition of NK1-receptor antagonists (NK1RA) in subsequent cycles in three highly or high-risk moderately emetogenic chemotherapy (HEC and high MEC) regimens', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 133 - 134, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Girgis A; Delaney GP; Arnold A; Durcinoska I; Gerges M; Kaadan N; Della-Fiorentina S, 2017, 'Does It Matter Who Addresses the Psychosocial Issues as Long as Someone Does?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 72 - 72, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kaadan N; Delaney G; Moylan E; Harvey M; Jobburn K; Boyd P; Tran T; Descallar J; Della-Fiorentina S, 2017, 'Monitoring Variations in Chemotherapy Prescribing Practices in South Western Sydney Local Health District', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 179 - 179, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Tervonen HE; Chen TY; Moylan E; Della-Fiorentina SA; Boyle F; Beith J; Currow DC, 2017, 'Risk of Emergency Hospitalisation Following Adjuvant Chemotherapy for Early Breast Cancer in NSW', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 171 - 171, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Parry JL; Della-Fiorentina SA; Yip PY; Bray V; Kiely BE, 2014, 'SURVIVAL TIMES OF PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) STARTING FIRST-LINE CHEMOTHERAPY IN ROUTINE CLINICAL PRACTICE VERSUS CONTEMPORARY RANDOMISED TRIALS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 159 - 160, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Moth EB; Beale P; Blinman P; Della-Fiorentina S; Parry J; Stockler MR; Kiely BE, 2014, 'DOCTOR-DOCTOR COMMUNICATION OF PROGNOSIS IN METASTATIC CANCER: A REVIEW OF LETTERS FROM MEDICAL ONCOLOGISTS TO REFERRING DOCTORS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 183 - 183, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hui M; Boxer M; Vinod SK; Della-Fiorentina SA; Blinman P, 2010, 'Uptake of adjuvant chemotherapy for NSCLC into routine clinical practice at the Liverpool and Macarthur Cancer Therapy centres', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. S29 - S30, presented at 3rd Australian Lung Cancer Conference, Melbourne Australia, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287990600108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Padinharakam S; Chua W; Lim S; Karikios D; Adams D; Della-Fiorentina S; Desouza P; Moylan E; Harrison M; Descallar J; Balakrishnar B, 2015, 'Patterns of care and outcomes among sarcomatoid renal cell carcinoma patients in South Western Sydney', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Vol. 11, pp. 180 - 180, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Wahlroos SSW; Della-Fiorentina S; Adams D; Hamilton B; Mok K; Kiely B, 2016, 'ADHERENCE TO ENDOCRINE THERAPY IN A REAL-WORLD COHORT OF WOMEN WITH EARLY BREAST CANCER TREATED AT TWO SYDNEY CANCER CENTERS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 112 - 112, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Zdenkowski N; Green M; Boyle FM; Kannourakis G; Gill PG; Bayliss E; Saunders C; Della-Fiorentina S; Kling N; Campbell I; Gebski V; Veillard A-S; Davies LC; Thornton R; Fong A; Reaby LL; Forbes JF, 2015, 'Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR plus ) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at 51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.514
Girgis A; Delaney G; Arnold A; Miller A; Carolan M; Della-Fiorentina S; Kaadan N; Avery S; van Domburg N; Ng W; Spring K; Van Kemenade C; Maher A, 2014, 'THE PROMPT-CARE PROJECT: EHEALTH SYSTEM UTILISING PATIENT REPORTED OUTCOMES TO INFORM PERSONALISED CANCER TREATMENT AND CARE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 21 - 21, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Girgis A; Delaney G; Arnold A; Miller A; Carolan M; Della-Fiorentina S; Kaadan N; Avery S; Domburg N; Ng W; Spring K; Jacobs J; Maher A, 2014, 'Translating Evidence into Practice Through the PROMPT-Care Project: Utilising Patient Reported Outcome Measures for Personalised Cancer Treatment and Care', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, Vol. 23, pp. 256 - 257, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344003700384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
CRICOS Provider Code: 00D98G
ABN 57 195 873 179
T +61 (2) 8738 3844
F +61 (2) 8738 3850
E swsydunsw@unsw.edu.au
UNSW, Liverpool Hospital
Locked Bag 7103
LIVERPOOL BC NSW 1871
Australia
Education and Research Centre
Liverpool Hospital
Eastern Campus
1 Burnside Dr
WARWICK FARM NSW 2170
Australia
Copyright © 2014 UNSW MEDICINE - South Western Sydney Clinical School
Authorised by South Western Sydney Clinical School - Page Last Updated:
13:32:33 PM, Saturday 26 February 2022